Medical oncology and Precision Medicine

All Items

• Exploring the somatic mutational landscape of ovarian cancer in Estonia

  Mikk Tooming, Kadri Rekker, Kadri Toome, Laura Roht, Piret Laidre, Olga Fjodorova, Ustina Šamarina, Sander Pajusalu, Mihkel Ilisson, Pilleriin Peets, Tõnu Jõgi, Karin Klaup, Kristiina Ojamaa, Eva-Maria Niine-Roolaht, Piret Kaarde, Elen Vettus, Jüri Piirsoo, Helen Vahar, Katrin Õunap, Tiina Kahre

  422-429

• A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma

  Suweydo Abdi, Paula Poikonen-Saksela, Päivi Halonen, Olli Tynninen, David A Reardon, Micaela Hernberg

  412-415

• PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set

  Maja B Drakenberg Danese, Christoffer P Vannas, Henrik A Fagman, Per O Karlsson, Karolina F Larsson

  401-405

• Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report

  Karen-Lise Garm Spindler, Christian Andreas Hvid, Lars Ulrik Fokdal, Karen Lycke Wind, Anne Vittrup Jakobsen, Rikke Løvendahl Eefsen, Eva Serup-Hansen

  394-400

• Tumour acquisition method and molecular profiling success in advanced cholangiocarcinoma

  Eleni Vrana, Alia Alothman, Luke Taylor, Joe Geraghty, Javaid Iqbal, Lucy Foster, Alicia-Marie Conway, Nadina Tinsley, Melissa Frizziero, Victoria Foy, Richard A Hubner, Mairéad G McNamara

  389-393

• Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis

  Aaron Caeyman, Giulia Mammone, Lisa Kinget, Marcella Baldewijns, Liesbeth De Wever, Maarten Albersen, Philip R Debruyne, Octavie Demeulenaere, Edward Scott McTaggart, Saurabh Saraswat, Charlien Berghen, Gert De Meerleer, Stefan Naulaerts, Abhishek D Garg, Benoit Beuselinck

  379-388

• SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer

  Karin Welén, Andreas Josefsson

  375-378

• Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancer

  Pascale J.M. Schafrat, Tim R. de Back, Felice N. van Erning, Frederieke H. van der Baan, Geraldine R. Vink, Miriam Koopman, Ruben S.A. Goedegebuure, Louis Vermeulen, Ignace H.J.T. de Hingh, Dirkje W. Sommeijer

  363-369

• Treatment of neuropathic pain in cancer survivors: a scoping review of pharmacological, exercise, and psychosocial interventions

  Ellen Lund Schaldemose, Bolette Skjødt Rafn, Pernille Envold Bidstrup, Agon Olloni, Katrin Schättiger, Peter Christensen, Cæcilie Borregaard Myrhøj, Maja Johannsen Lindberg, Christoffer Johansen, Sandra Jensen, Ida Hovdenak, Sasja Jul Håkonsen, Lise Ventzel

  333-343

• The role of radiotherapy in patients with advanced melanoma failing targeted therapy

  Ellen Heurlin, Lina Grödeberg, Hildur Helgadottir

  344-354